AI Agentic Workflow for Ophthalmology Diabetic Retinopathy Screening

Automates the initial grading of retinal images against the International Clinical Diabetic Retinopathy scale, performing a task that consumes 5-10 minutes of a specialist's time per scan. This allows a single ophthalmologist or optometrist to oversee the screening of hundreds more patients per month, effectively decoupling screening capacity from specialist availability and enabling broader population health initiatives.

Generates a structured screening report with severity grade, visual evidence markup, and clear follow-up recommendations (e.g., 'routine screening in 12 months,' 'refer to ophthalmologist within 4 weeks') within seconds of image upload. This eliminates manual report drafting and fax/phone delays, ensuring PCPs receive actionable guidance 3-5 days faster, which directly reduces the risk of vision loss from delayed intervention.

Replaces manual data entry, image sorting, and basic report templating—tasks typically performed by ophthalmic technicians or administrative staff. By handling image ingestion, grading rationale documentation, and report assembly, the workflow reduces the labor cost per screening by 40-60%, turning a clinician-intensive process into a scalable, tech-enabled service line for health systems and payers.

Applies the same objective, guideline-based criteria to every image, eliminating inter-grader variability. Every decision is paired with an explainability layer highlighting the lesions (microaneurysms, hemorrhages, neovascularization) that drove the grade. This creates a defensible, searchable audit trail for quality reporting, payer reviews, and accreditation (e.g., ADA, NCQA), reducing compliance overhead and denials.

Creates a structured, coded data output (severity grade, laterality, findings) that integrates directly with EHRs and population health platforms. This enables automated quality measure calculation (e.g., HEDIS Eye Exam), supports hierarchical condition category (HCC) coding for diabetic retinopathy, and provides the data foundation for risk-adjusted capitation or pay-for-performance contracts in value-based arrangements.

Implementation follows a controlled pilot: the workflow initially operates in a 'human-in-the-loop' mode where all grades are confirmed by a clinician, building trust and refining logic. After validation, it shifts to 'human-on-the-loop' for low-risk cases, auto-escalating uncertain or high-severity images. This phased approach derisks adoption, ensures clinical safety, and typically achieves full operational scale within 8-12 weeks.

This agent orchestrates the secure intake of retinal images from fundus cameras, OCT devices, or telehealth platforms. It validates DICOM headers, performs quality checks (focus, illumination, field of view), and standardizes images for analysis. Failed quality checks trigger automated re-capture requests or routing to a human technician queue, preventing garbage-in, garbage-out scenarios in the diagnostic pipeline.

The core diagnostic agent applies a validated deep learning model (e.g., based on ICDR/ETDRS standards) to grade images for diabetic retinopathy (DR) and diabetic macular edema (DME). Crucially, it generates a saliency map or heatmap overlay highlighting microaneurysms, hemorrhages, and exudates that informed the severity score (No DR, Mild, Moderate, Severe, Proliferative). This visual explainability layer is appended to the report, creating a defensible link between image pixels and clinical output for practitioner review and audit.

This agent synthesizes the severity grade, patient demographics, and historical data (if available) into a structured screening report. It drafts clear, guideline-based follow-up recommendations (e.g., 'Annual screening', 'Refer to ophthalmologist within 3 months', 'Urgent referral'). The agent ensures language aligns with the American Academy of Ophthalmology Preferred Practice Patterns, and all recommendations are explicitly tied to the graded findings, creating a compliance-ready narrative.

The central workflow engine manages data flow and business logic. It routes finalized reports based on severity: normal/mild results to the patient portal and PCP's EHR inbox; moderate/severe cases trigger direct EHR inbox alerts for the PCP and can auto-populate referral orders to ophthalmology. It integrates with EHRs (Epic, Cerner) via FHIR APIs and maintains a complete audit log of every image, grade, report version, and routing action for HIPAA and quality reporting.

A dedicated dashboard for ophthalmologists or trained reviewers to handle exceptions. It presents cases where grading confidence is low, images are borderline between severity levels, or the system flags potential pathologies beyond DR/DME. Reviewers can override grades with comments, which are fed back to improve the model. This console ensures final clinical oversight, fulfills regulatory requirements for physician responsibility, and serves as the system's quality control checkpoint.

A backend system that continuously monitors the workflow's performance and compliance posture. It tracks key metrics: screening volume, positivity rates, referral completion rates, and turn-around times. It also runs periodic bias checks on grading outcomes across demographic subgroups and maintains an immutable audit trail of all model versions, data used for inference, and user actions. This layer generates reports for quality improvement committees and prepares documentation for regulatory surveys (e.g., CLIA, FDA SaMD if applicable).

Owns clinical validity and liability. Approves the grading logic against the International Clinical Diabetic Retinopathy scale, defines the scope of AI-assisted findings versus definitive diagnosis, and signs off on the referral protocol embedded in the report. Their primary concern is ensuring the workflow augments, rather than replaces, the physician's judgment and maintains a clear chain of accountability.

Governs data handling, auditability, and regulatory alignment. Mandates HIPAA-compliant image ingestion, enforces strict de-identification before model processing, and requires immutable audit logs for every screening event—from image upload to report generation. They define the requirements for the explainability layer, ensuring every AI-generated finding can be traced back to specific image features for potential FDA audit or malpractice review.

Designs the production orchestration. Selects the model serving platform (e.g., TensorFlow Serving, TorchServe), implements the agentic workflow logic (likely using LangGraph for state management), and builds the integration APIs to the PACS/VNA for image retrieval and the EHR for report delivery. They are responsible for the non-functional requirements: latency (<5 sec for inference), uptime (99.9% SLA), and the rollback strategy if model performance drifts.

Manages the human-in-the-loop process and operational scaling. Defines the exception-handling queue for low-confidence gradings or unreadable images, trains the ophthalmic technicians on the new intake workflow, and establishes the service-level agreement (SLA) for report turnaround to PCPs (e.g., <24 hours). They measure the throughput gain (patients screened per clinician hour) and coordinate the phased rollout from pilot clinic to network-wide deployment.

Ensures systems integration and data pipeline integrity. Manages the HL7/FHIR interfaces between the screening platform, the EHR (e.g., Epic, Cerner), and the imaging archive. Validates the data mapping for report fields (LOINC codes for severity, SNOMED for findings) and oversees the secure, encrypted transfer of both images and structured data. They are the gatekeeper for production system access, change management, and ongoing interoperability monitoring.

Implements continuous monitoring and performance governance. Establishes the ground-truth reconciliation process where a subset of AI reports is reviewed by a retinal specialist to track accuracy (sensitivity/specificity). They define the key risk metrics: false negative rate (must be near zero), positive predictive value, and the escalation protocol for any discrepancy. Their dashboard drives model retraining triggers and provides the evidence for ongoing clinical and regulatory endorsement.